Growth Metrics

Nexalin Technology (NXL) Gross Margin (2021 - 2026)

Nexalin Technology's quarterly Gross Margin came in at 87.85% in Q1 2026, up 2090.0% year-on-year from 4.01% in Q1 2025, and little changed quarter-over-quarter from 87.77% in Q4 2025.

Nexalin Technology has reported Gross Margin for 6 years, with the latest figure at 87.85% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 2090.0% year-over-year to 87.85%; the trailing twelve-month figure through Mar 2026 stood at 81.99% (up 1327.0% YoY), and the FY2025 full-year result was 79.65%, up 134.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 87.85%, roughly flat from 87.77% in the prior quarter.
  • The five-year high for Gross Margin was 88.36% in Q1 2024, with the low at 64.77% in Q3 2024.
  • Average Gross Margin over 5 years is 76.43%, with a median of 74.53% recorded in 2023.
  • Year-over-year, Gross Margin sank 2206 bps in 2022 and jumped 2090 bps in 2026.
  • Tracing NXL's Gross Margin over 5 years: stood at 82.13% in 2022, then decreased by 9 bps to 74.53% in 2023, then decreased by 3 bps to 72.42% in 2024, then climbed by 21 bps to 87.77% in 2025, then climbed by 0 bps to 87.85% in 2026.
  • The last three Gross Margin figures came in at 87.85% (Q1 2026), 87.77% (Q4 2025), and 78.25% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 56.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 63.29%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 63.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 38.53%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 43.89%
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 87.85%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 87.85%
Dec 31, 2025 87.77%
Sep 30, 2025 78.25%
Jun 30, 2025 67.65%
Mar 31, 2025 66.94%
Dec 31, 2024 72.42%
Sep 30, 2024 64.77%
Jun 30, 2024 73.00%
Mar 31, 2024 88.36%
Dec 31, 2023 74.53%
Sep 30, 2023 83.52%
Jun 30, 2023 73.62%
Mar 31, 2023 76.73%
Dec 31, 2022 82.13%
Sep 30, 2022 65.65%
Jun 30, 2022 70.30%
Mar 31, 2022 85.77%
Dec 31, 2021 104.19%
Sep 30, 2021 83.37%